| 000 | 02784nam a22003375i 4500 | ||
|---|---|---|---|
| 999 |
_c399172 _d399172 |
||
| 001 | 399172 | ||
| 003 | ES-MaUEC | ||
| 005 | 20240408103525.0 | ||
| 006 | a||||fo|||| 00| 0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 230717s2023 sz | o |||| 0|eng d | ||
| 020 | _a9783031358074 | ||
| 024 | 7 |
_a10.1007/978-3-031-35807-4 _2doi |
|
| 040 |
_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC |
||
| 050 | 4 |
_aRC152.5 _b2023 EB |
|
| 245 | 0 | 0 |
_aLassa Fever : _bEpidemiology, Immunology, Diagnostics, and Therapeutics _cedited by Robert Garry |
| 250 | _a1st ed. 2023. | ||
| 264 | 1 |
_aCham _bSpringer International Publishing _c2023 |
|
| 300 | _a1 recurso en línea | ||
| 336 |
_atexto _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 490 | 0 |
_aCurrent Topics in Microbiology and Immunology _x2196-9965 _v440 |
|
| 505 | 0 | _a50 years of Lassa fever research -- Lassa Virus Genetics -- Ecology of Lassa virus -- Epidemiology of Lassa Fever -- Lassa virus countermeasures -- Lassa virus structural biology and replication -- Lassa Fever Natural History and Clinical Management. | |
| 520 | _aThis volume provides a comprehensive and up-to-date overview of the various aspects of Lassa virus (LASV), the causative agent of Lassa fever, a frequently fatal zoonotic disease endemic to West Africa. Compiled by world-leading experts in the field, this book provides an introduction to the 50-year history of Lassa fever research, the genetic diversity of LASV, and its geographic distribution. Subsequent chapters focus on the ecology and epidemiology of LASV, discussing in-depth the interactions of the virus with its hosts - multimammate mice and other rodents - and the interactions between these animal reservoirs and humans. The book also details the many advances in understanding the structural biology and replication of LASV, including new insights into the structure and function of its proteins. These advances in the basic understanding of LASV biology have enabled the development of LASV countermeasures, including sensitive and specific diagnostic assays. Promising drug candidates, including monoclonal antibodies, and vaccines are also discussed. A final and essential chapter addresses current and future clinical practice for clinical management of Lassa fever. This volume is intended for researchers and clinicians in the fields of virology, epidemiology, and microbiology. | ||
| 988 | _aSpringer_BiomedLife_2023 | ||
| 650 | 7 |
_2embne _9138404 _aEnfermedades infecciosas |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-031-35807-4 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 942 |
_2lcc _cLE |
||
| 998 |
_b04/2024 _dz _ek _zSI |
||